We are live on ! Find out more
CCEL icon

Cryo-Cell International

14 hedge funds and large institutions have $4.25M invested in Cryo-Cell International in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more funds holding

Funds holding: 1314 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.62% less ownership

Funds ownership: 8.92%8.3% (-0.62%)

5% less capital invested

Capital invested by funds: $4.45M → $4.25M (-$209K)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
1
Reduced
5
Closed
Calls
Puts
Net Calls
Net Calls Change

CCEL Hedge Fund Activity: Q3 2022 in Review

14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q3 2022, worth a combined $4.25M — down 4.7% from $4.45M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CCEL positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 5 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $118K. The largest seller was ISZO Capital Management, cutting an estimated $458K.

  • 14 institutional investors held Cryo-Cell International (CCEL) as of Q3 2022, up from 13 in Q2 2022.
  • Funds reported $4.25M of Cryo-Cell International stock for Q3 2022, down 4.7% quarter-over-quarter.
  • 1 fund opened new Cryo-Cell International positions in Q3 2022 and 0 closed out, a net change of +1 holder.
  • The largest Cryo-Cell International buyer in Q3 2022 was Geode Capital Management, an estimated $118K added.
  • The largest Cryo-Cell International seller in Q3 2022 was ISZO Capital Management, an estimated $458K sold.

Based on aggregated 13F filings for Q3 2022.